Results 191 to 200 of about 2,209,264 (388)

Disclosure Updated [PDF]

JAMA, 2022
openaire   +2 more sources

Traditional healers can help facilitate HIV serostatus disclosure: results from a qualitative study in rural Uganda. [PDF]

J Int AIDS Soc
Gogineni S, Nuwagaba G, Hooda M, Natukunda S, Birungi C, Bugeza W, Tushabe M, Nansera D, Muyindike W, Audet CM, Mwanga-Amumpaire J, Sundararajan R.   +11 more
europepmc   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

Determinants of voluntary bank disclosure: evidence from Japanese Shinkin banks [PDF]

Disclosure is widely regarded as a necessary condition for market discipline in a modern financial sector. However, the determinants of disclosure decisions are still unknown, particularly among banks.
Mark M. Spiegel, Nobuyoshi Yamori
core  

Disclosing HIV status to sexual partner: Findings from a People Living with HIV Stigma Index 2.0 study in the country Georgia. [PDF]

PLoS One
Zurashvili T, Pashalishvili M, Earnshaw VA, Do H, Zakareishvili N, DeHovitz J, Walters SM, Djibuti M.   +7 more
europepmc   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Factors Influencing Lesbians' Direct Disclosure of Their Sexual Orientation [PDF]

, 1996
Vivien E. Radonsky, L. DiAnne Borders
openalex   +1 more source

Investigating the effect of emotional disclosure on the quality of life of women after abortion: a randomized controlled clinical trial. [PDF]

BMC Psychol
Salarfard M, Ghannadkafi M, Vaghee S, Behnam Vashani H, Mirzakhani K.   +4 more
europepmc   +1 more source

Data‐driven discovery of gene expression markers distinguishing pediatric acute lymphoblastic leukemia subtypes

Molecular Oncology, EarlyView.
This study investigates gene expression differences between two major pediatric acute lymphoblastic leukemia (ALL) subtypes, B‐cell precursor ALL, and T‐cell ALL, using a data‐driven approach consisting of biostatistics and machine learning methods. Following analysis of a discovery dataset, we find a set of 14 expression markers differentiating the ...
Mona Nourbakhsh, Nikola Tom, Anna Schrøder Lassen, Helene Brasch Lind Petersen, Ulrik Kristoffer Stoltze, Karin Wadt, Kjeld Schmiegelow, Matteo Tiberti, Elena Papaleo   +8 more
wiley   +1 more source

Test Disclosure and Retest Performance on the SAT

, 1984
Lawrence J. Stricker
openalex   +2 more sources